MESORIDAZINE AND THIORIDAZINE

被引：0
|
作者：
RICHELSON, E
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 1987年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：344 / 344
页数：1
相关论文
共 50 条
  • [21] ISOLATION OF A POSSIBLE NEW METABOLITE IN HUMAN PLASMA FOLLOWING THIORIDAZINE AND MESORIDAZINE ADMINISTRATION
    DINOVO, EC
    GOTTSCHALK, LA
    NOBLE, EP
    BIENER, R
    PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1974, 17 : 110 - 111
  • [22] REVERSE-PHASE HPLC DETERMINATION OF THIORIDAZINE AND MESORIDAZINE IN WHOLE-BLOOD
    MCCUTCHEON, JR
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1979, 3 (03) : 105 - 107
  • [23] GREATER POTENCY OF MESORIDAZINE AND SULFORIDAZINE COMPARED WITH THE PARENT COMPOUND, THIORIDAZINE, ON STRIATAL DOPAMINE AUTORECEPTORS
    NIEDZWIECKI, DM
    MAILMAN, RB
    CUBEDDU, LX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1984, 228 (03): : 636 - 639
  • [24] UVA-INDUCED GENETIC-EFFECTS OF THIORIDAZINE, MESORIDAZINE AND SULFORIDAZINE - AN INVITRO STUDY
    SCHOONDERWOERD, SA
    VANHENEGOUWEN, GMJB
    PANDAY, IR
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 1990, 45 (06): : 638 - 644
  • [25] Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses
    Salih, I. S. M.
    Thanacoody, R. H. K.
    McKay, G. A.
    Thomas, S. H. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) : 548 - 554
  • [26] Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity
    Llerena, A
    Berecz, R
    de la Rubia, A
    Norberto, MJ
    Benítez, J
    THERAPEUTIC DRUG MONITORING, 2000, 22 (04) : 397 - 401
  • [27] RED-BLOOD-CELL AND PLASMA-LEVELS OF THIORIDAZINE AND MESORIDAZINE IN SCHIZOPHRENIC-PATIENTS
    SHVARTSBURD, A
    NWOKEAFOR, V
    SMITH, RC
    PSYCHOPHARMACOLOGY, 1984, 82 (1-2) : 55 - 61
  • [28] Relevance of CYP1A2 for thioridazine, mesoridazine sulforidazine plasma concentration in psychiatric patients
    Dorado, P.
    Cáceres, M. C.
    Peñas-Lledó, E. M.
    Gonzalez, I
    de la Rubia, A.
    LLerena, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 50 - 51
  • [29] TREATMENT WITH MESORIDAZINE AND THIORIDAZINE IN CHRONIC-SCHIZOPHRENIA .2. POTENTIAL PREDICTORS OF DRUG RESPONSE
    GARDOS, G
    TECCE, JJ
    HARTMANN, E
    BOWERS, P
    COLE, JO
    COMPREHENSIVE PSYCHIATRY, 1978, 19 (06) : 527 - 532
  • [30] A STUDY OF THIORIDAZINE AND ITS SIDE-CHAIN DERIVATIVE MESORIDAZINE IN CHRONIC MALE HOSPITALIZED PSYCHIATRIC PATIENTS
    MENA, A
    GRAYSON, H
    COHEN, S
    JOURNAL OF NEW DRUGS, 1966, 6 (06): : 345 - &
12345